UBX - Unity Biotechnology, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5278.41M
Enterprise Value 3165.43M
Trailing P/E N/A
Forward P/E 1-2.34
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)N/A
Price/Book (mrq)2.33
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 6-1.90

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 3-46.59%
S&P500 52-Week Change 321.38%
52 Week High 312.03
52 Week Low 35.61
50-Day Moving Average 36.83
200-Day Moving Average 36.86

Share Statistics

Avg Vol (3 month) 3207.25k
Avg Vol (10 day) 3100.82k
Shares Outstanding 545.94M
Float 25.63M
% Held by Insiders 119.60%
% Held by Institutions 175.48%
Shares Short (Jan 30, 2020) 45.28M
Short Ratio (Jan 30, 2020) 430.62
Short % of Float (Jan 30, 2020) 424.21%
Short % of Shares Outstanding (Jan 30, 2020) 411.50%
Shares Short (prior month Dec 30, 2019) 44.94M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2018
Most Recent Quarter (mrq)Sep 29, 2019


Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-32.90%
Return on Equity (ttm)-58.50%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)-58.91M
EBITDA -87.06M
Net Income Avi to Common (ttm)-86.07M
Diluted EPS (ttm)-2.03
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)112.97M
Total Cash Per Share (mrq)2.46
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)8.79
Book Value Per Share (mrq)2.60

Cash Flow Statement

Operating Cash Flow (ttm)-69.54M
Levered Free Cash Flow (ttm)-53.26M